New hope of gene therapy results from improvements of lentiviral vectors-review.
10.7534/j.issn.1009-2137.2013.05.050
- Author:
Fang FANG
1
;
Ping ZHU
Author Information
1. Department of Hematology, Peking University First Hospital, Beijing 100034, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Genetic Therapy;
Genetic Vectors;
Humans;
Lentivirus;
genetics;
Transfection
- From:
Journal of Experimental Hematology
2013;21(5):1336-1339
- CountryChina
- Language:Chinese
-
Abstract:
Gene therapy has been considered as one of the optimal treatments. Although, at the beginning of this century, a series of unexpected side effects brought gene therapy into depression, the improved lentiviral vectors, which characterised by high efficiency transfection, stable expression in target cells and good biosafety, have been applied in clinical trials in recent years and acquired a certain clinical improvements. Nowadays gene therapy becomes an eye-catching field. This review discusses the gene therapy how blocked by lentiviral vectors, the high efficiency and biosafety of lentiviral vectors, the improvement of lentiviral vector preparation and so on.
